NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

I hear you. I think you just need more accurate, current, and trustworthy sources.

Here are three current developments:

1. Recent press conference highlighting both the P3 and the interim results of the pembrolizumab combo study at UCLA

2. NICE

3. Legal action against manipulation (some general and some directly related).

Skip to about 6:30 of the video to hear Dr. Toms also briefly highlight the pembrolizumab combo study at UCLA!

https://clinicaltrials.gov/ct2/show/NCT0420187



https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847



https://ceoworld.biz/2022/04/05/top-5-medical-journals-in-the-world-everyone-should-know-about/

The forthcoming NICE developments will further validate the P3 data and the significance of this landmark study. These developments could unfold soon and in advance of the FDA.

https://www.nice.org.uk/guidance/indevelopment/gid-ta10143

Don’t miss this interview tomorrow:

Join Wes Christian & me LIVE Wed 18 Jan, 9.30am PT / 12.30pm ET here: https://t.co/rqQTkPXwj3 to hear the actions Wes & CEOs are taking against naked short sellers and “The Motherload” of #NakedShorts being exposed $GNS, $CRTD, $GTII $FNGR $TRCH $MMAT $MMTLP $GME $AMC $WULF $BBIG pic.twitter.com/ozS1usMRky

— Roger James Hamilton (@rogerhamilton) January 17, 2023

https://www.youtube.com/rogerhamiltontv

https://christianlevinelaw.com/lawyer/james-wesley-christian/